Phosphorylation of spleen tyrosine kinase at Y346 negatively regulates ITAM-mediated signaling and function in platelets

Spleen tyrosine kinase (Syk) is expressed in a variety of hemopoietic cells. Upon phosphorylation of the platelet immunoreceptor–based activation motif of the glycoprotein VI (GPVI)/Fc receptor gamma chain collagen receptor, both the tyrosine phosphorylation and activity of Syk are increased leading...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2023-07, Vol.299 (7), p.104865-104865, Article 104865
Main Authors: Dangelmaier, Carol A., Patchin, Margaret, Vajipayajula, Dhruv N., Vari, Hymavathi Reddy, Singh, Pankaj K., Wright, Monica N., Kostyak, John C., Tsygankov, Alexander Y., Kunapuli, Satya P.
Format: Article
Language:English
Subjects:
Animals
Blood Platelets
Collection: Signal Transduction
hemostasis
Mice
Phosphorylation
platelet
Platelet Activation
Platelet Aggregation
Platelet Membrane Glycoproteins - genetics
Platelet Membrane Glycoproteins - metabolism
spleen tyrosine kinase
Syk Kinase - genetics
Syk Kinase - metabolism
thrombosis
Tyrosine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Spleen tyrosine kinase (Syk) is expressed in a variety of hemopoietic cells. Upon phosphorylation of the platelet immunoreceptor–based activation motif of the glycoprotein VI (GPVI)/Fc receptor gamma chain collagen receptor, both the tyrosine phosphorylation and activity of Syk are increased leading to downstream signaling events. Although it has been established that the activity of Syk is regulated by tyrosine phosphorylation, the specific roles of individual phosphorylation sites remain to be elucidated. We observed that Syk Y346 in mouse platelets was still phosphorylated when GPVI-induced Syk activity was inhibited. We then generated Syk Y346F mice and analyzed the effect this mutation exerts on platelet responses. Syk Y346F mice bred normally, and their blood cell count was unaltered. We did observe potentiation of GPVI-induced platelet aggregation and ATP secretion as well as increased phosphorylation of other tyrosines on Syk in the Syk Y346F mouse platelets when compared to WT littermates. This phenotype was specific for GPVI-dependent activation, since it was not seen when AYPGKF, a PAR4 agonist, or 2-MeSADP, a purinergic receptor agonist, was used to activate platelets. Despite a clear effect of Syk Y346F on GPVI-mediated signaling and cellular responses, there was no effect of this mutation on hemostasis as measured by tail-bleeding times, although the time to thrombus formation determined using the ferric chloride injury model was reduced. Thus, our results indicate a significant effect of Syk Y346F on platelet activation and responses in vitro and reveal its complex nature manifesting itself by the diversified translation of platelet activation into physiological responses.
ISSN:0021-9258
1083-351X
DOI:10.1016/j.jbc.2023.104865